• Work With Us
    • Partnerships
      • We offer tailored partnerships to support and transform drug discovery.

        Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

    • Services
      • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

        As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

    • OrganoReady®
      • Our OrganoReady program is made for you when you need defined assays in ADME.

        We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Resources & Support
    • Knowledge Center
      • Get inspired by peer-reviewed publications, webinars, whitepapers, app notes and more in our knowledge center.

    • Blogs
      • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
    • Case Studies
      • Get inspired by research done by our scientists, partners, and customers around the globe.

    • Webinars & Events
    • Applications
  • About MIMETAS
  • News
  • We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need defined assays in ADME.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Get inspired by peer-reviewed publications, webinars, whitepapers, app notes and more in our knowledge center.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

MIMETAS launches assay ready product line for Organ-on-a-Chip

Innovative in vitro models ready-to-use for safety, ADME, and toxicology studies in drug development and food & nutrition research.

Leiden, March 3, 2020 – MIMETAS announces the first product release of her Assay Ready product line: OrganoReady® Caco-2. The product consists of 38 intestinal tubules that are grown under flow conditions against an extracellular matrix. According to Bas Trietsch, Chief Technology Officer at MIMETAS, the launch of this first Assay Ready product is a significant next step in making Organ-on-a-Chip technology available to all. 'With this new product line, our customers are served with the best 3D biological models in an Assay Ready format. This results in a tremendous reduction of time and effort spent by our customers. In fact, the customer receives a fully quality-controlled, ready-to-use tissue model, alleviating the need for licensing negotiations and banking, expansion, and culturing of the cells.'

The OrganoReady Caco-2 features 38 Caco-2 tubules and two controls. Caco-2 is a human colon adenocarcinoma cell line with a well-preserved barrier, receptor, and transporter characteristics. 'The Caco-2 cell line is a widely adopted industry standard, with years of legacy' says Trietsch. “For this reason, we decided to launch this product first.” “We foresee the use of the product in ADME, safety-, toxicology- and mechanistic studies for drug development, but also in the food and dairy industry who have an increasing interest in validating health claims of their products.”

Trietsch reveals that the Caco-2 product will be the first in a line-up of products that will further support the adoption of Organ-on-a-Chip: “From now on, the fully mature tissue is incorporated in the chip, rather than buying just the chip. MIMETAS will take care of the tissue culture, allowing our customers to maximally focus on their research questions and core business.”

OrganoReady Caco-2

Cookies

‘May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy

Accept all
Accept selected
Decline all